Summary
Human plasma low density lipoporteins (LDL) are the major carriers of cholesterol and cholesteryl esters in the circulation. Their increased levels correlate positively with increased risk of coronary artery disease. LDL contain a single major apolipoprotein of apparent molecualr weight (Mr) = 550,000, designated apolipoprotein B-100 (apoB-100), and ins ome LDL preparations, minor components termed apoB-74 (410,000) and apoB-26 (145,000). The structural relationship of the apoB-74 and -26 proteins to the apoB-100 has remained obscure and their roles in cholesterol metabolism are unknown. In the present study, we show that the addition of kaolin to plasma anticoagulated with EDTA induces the proteolytic cleavage of apoB-100. As a result, two apoB peptides are produced with Mr indistinguishable from plasma apoB-74 and -26. The specific cleavage of apoB-100 was mimicked in vitro by purified human plasma and tissue kallikreins. In contrast, thrombin, factor Xa, plasmin, trypsin, and chymotrypsin did not produce these peptides when incubated with LDL. The findings of the study suggest that apoB-74 and -26 are proteolytic fragments of apoB-100 and that the endogenous protease has a kallikrein-like specificity for DLD-apoB-100. The role of plasma and tissue kallikreins in cholesterol metabolism remains to be determined.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
J. L. Goldstein and M. S. Brown, The low-density lipoprotein pathway and its relation to atherosclerosis, Ann. Rev. Biochem., 46:897– 930 (1977).
J. P. Kane, D. A. Hardman, and H. E. Paulus, Heterogeneity of apolipoprotein B: Isolation of a new species from human chylomicrons, Proc. Natl. Acad. Sci. USA, 77: 2465–2469 (1980).
M. J. Malloy, J. P. Kane, D. A. Hardman, R. L. Hamilton, and K. B. Dalai, Normotriglyceridemic abetalipoproteinemia: Absence of the B-100 apolipoprotein, J. Clin. Invest., 67: 1441–1450 (1981).
K. Shimamoto, J. Chao, and H. S. Margolius, The radioimmunoassay of human urinary kallikrein and comparisons with kallikrein activity measurements, J. Clin. Endocrinol. Metab., 51: 840–848 (1980).
J. Chao, S. Tanaka, and H. S. Margolius, Inhibitory effects of sodium and other monovalent cations on purified versus membrane-bound kallikrein, J. Biol. Chem., 258: 6461–6465 (1983).
H. Nagase and A. J. Barrett, Human plasma kallikrein: A rapid purification method with high yield, Biochem. J., 193: 187–192 (1981).
V. H. Donaldson, R. A. Harrison, F. A. Rosen, D. H. Bing, G. Kindness, J. Canar, C. J. Wagner, and S. Awad, Variability in purified dysfunctional C1-inhibitor protein frompatients with hereditary angioneurotic edema, J. Clin. Invest., 75: 1–9 (1985).
H. Saito, O. D. Ratnoff, and V. H. Donaldson, Defective activation of clotting, fibrinolytic, and permeability-enhancing systems in human Fletcher trait plasma, Circ. Res., 34: 641–651 (1974).
A. D. Cardin, K. R. Witt, C. L. Barnhart, and R. L. Jackson, Sulfhydryl chemistry and solubility properties of humanplasma apolipoprotein B, Biochemistry, 21: 4503–4511 (1982).
A. D. Cardin, K. R. Witt, J. Chao, H. S. Margolius, V. H. Donaldson, and R. L. Jackson, Degradation of apolipoprotein B-100 of human plasma low density lipoproteins by tissue and plasma kallikreins, J. Biol. Chem., 259: 8522–8528 (1984).
H. Towbin, T. Staehelin, and J. Gordon, Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedure and some applciations, Proc. Natl. Acad. Sci. USA, 76: 4350–4354 (1979).
J. M. Gershoni and G. E. Palade, Protein blotting: Principles and applciations, Anal. Biochem., 131: 1–15 (1983).
O. H. Lowry, N. J. Rosebrough, A. L. Farr, and R. J. Randall, Protein measurement with the folin phenol reagent, J. Biol. Chem., 193: 265–275 (1951).
K. Shimamoto, R. K. Mayfield, H. S. Margolius, J. Chao, W. Stroud, and A. P. Kaplan, Immunoreactive tissue kallikrein in human serum, J. Lab. Clin. Med., 103: 731–738 (1984).
T. S. Paskhina, L. R. Polyantseva, A. V. Krinskaya, T. P. Egorova, V. Ph. Nartikova, I. M. Karmansky, and R. I. Yakubovskaya, Components of KKKK system in plasma and edematous fluids of patients with nephrotic syndrome (NS): Compensatory and pathogenetic role of kinins in nephrotic syndrome, Adv. Exp. Med. Biol., 156B: 1119–1125 (1983).
R. Ross, The arterial wall and atherosclerosis, Ann. Rev. Med., 30: 1 – 15 (1979).
H. Nolly and M. C. Lama, Vascular kallikrein: A kallikrein-like enzyme present in vascular tissue of the rat, Clin. Sci. (Lond.), 63: 249s–251s (1982).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1986 Plenum Press, New York
About this chapter
Cite this chapter
Cardin, A.D., Jackson, R.L., Donaldson, V.H., Chao, J., Margolius, H.S. (1986). Processing of Apolipoprotein B-100 of Human Plasma Low Density Lipoproteins by Tissue and Plasma Kallikreins. In: Greenbaum, L.M., Margolius, H.S. (eds) Kinins IV. Advances in Experimental Medicine and Biology, vol 198A. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-5143-6_27
Download citation
DOI: https://doi.org/10.1007/978-1-4684-5143-6_27
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-5145-0
Online ISBN: 978-1-4684-5143-6
eBook Packages: Springer Book Archive